 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Previous Article | Next Article
The Journal of Neuroscience, April 1, 1999, 19(7):2706-2716
Reorganization of Cholinergic Terminals in the Cerebral Cortex and Hippocampus in Transgenic Mice Carrying Mutated Presenilin-1 and Amyloid Precursor Protein Transgenes
Tak Pan Wong1, Thomas Debeir1, Karen Duff2, and A. Claudio Cuello1 1 Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada, H3G 1Y6, and 2 Nathan Kline Institute, Orangeburg, New York 10962
Cholinergic deficits are one of the most consistent neuropathological landmarks in Alzheimer's disease (AD). We have examined transgenic mouse models (PS1M146L, APPK670N,M671L) and a doubly transgenic line (APPK670N,M671L + PS1M146L) that overexpress mutated AD-related genes [presenilin-1 (PS1) and the amyloid precursor protein (APP)] to investigate the effect of AD-related gene overexpression and/or amyloidosis on cholinergic parameters.
The size of the basal forebrain cholinergic neurons and the pattern of cholinergic synapses in the hippocampus and cerebral cortex were revealed by immunohistochemical staining for choline acetyltransferase and the vesicular acetylcholine transporter, respectively. At the time point studied (8 months), no apparent changes in either the size or density of cholinergic synapses were found in the PS1M146L mutant relative to the nontransgenic controls. However, the APPK670N,M671L mutant showed a significant elevation in the density of cholinergic synapses in the frontal and parietal cortices. Most importantly, the double mutant (APPK670N,M671L + PS1M146L), which had extensive amyloidosis, demonstrated a prominent diminution in the density of cholinergic synapses in the frontal cortex and a reduction in the size of these synapses in the frontal cortex and hippocampus. Nonetheless, no significant changes in the size of basal forebrain cholinergic neurons were observed in these three mutants. This study shows a novel role of APP and a synergistic effect of APP and PS1 that correlates with amyloid load on the reorganization of the cholinergic network in the cerebral cortex and hippocampus at the time point studied.
Key words: Alzheimer's disease; cholinergic synapse; amyloid precursor protein; presenilin-1; transgenic mice; vesicular acetylcholine transporter
Copyright © 1999 Society for Neuroscience 0270-6474/99/1972706-11$05.00/0
This article has been cited by other articles:
P. Aracri, S. Consonni, R. Morini, M. Perrella, S. Rodighiero, A. Amadeo, and A. Becchetti
Tonic Modulation of GABA Release by Nicotinic Acetylcholine Receptors in Layer V of the Murine Prefrontal Cortex
Cereb Cortex, October 7, 2009; (2009) bhp214v1.
[Abstract] [Full Text] [PDF]
J. K. Knowles, J. Rajadas, T.-V. V. Nguyen, T. Yang, M. C. LeMieux, L. Vander Griend, C. Ishikawa, S. M. Massa, T. Wyss-Coray, and F. M. Longo
The p75 Neurotrophin Receptor Promotes Amyloid-{beta}(1-42)-Induced Neuritic Dystrophy In Vitro and In Vivo
J. Neurosci., August 26, 2009; 29(34): 10627 - 10637.
[Abstract] [Full Text] [PDF]
Y. Liu, M.-J. Yoo, A. Savonenko, W. Stirling, D. L. Price, D. R. Borchelt, L. Mamounas, W. E. Lyons, M. E. Blue, and M. K. Lee
Amyloid Pathology Is Associated with Progressive Monoaminergic Neurodegeneration in a Transgenic Mouse Model of Alzheimer's Disease
J. Neurosci., December 17, 2008; 28(51): 13805 - 13814.
[Abstract] [Full Text] [PDF]
G. B. Stokin, A. Almenar-Queralt, S. Gunawardena, E. M. Rodrigues, T. Falzone, J. Kim, C. Lillo, S. L. Mount, E. A. Roberts, E. McGowan, et al.
Amyloid precursor protein-induced axonopathies are independent of amyloid-{beta} peptides
Hum. Mol. Genet., November 15, 2008; 17(22): 3474 - 3486.
[Abstract] [Full Text] [PDF]
C. L. Scheiderer, E. McCutchen, E. E. Thacker, K. Kolasa, M. K. Ward, D. Parsons, L. E. Harrell, L. E. Dobrunz, and L. L. McMahon
Sympathetic sprouting drives hippocampal cholinergic reinnervation that prevents loss of a muscarinic receptor-dependent long-term depression at CA3-CA1 synapses.
J. Neurosci., April 5, 2006; 26(14): 3745 - 3756.
[Abstract] [Full Text] [PDF]
M. T. Heneka, M. Ramanathan, A. H. Jacobs, L. Dumitrescu-Ozimek, A. Bilkei-Gorzo, T. Debeir, M. Sastre, N. Galldiks, A. Zimmer, M. Hoehn, et al.
Locus Ceruleus Degeneration Promotes Alzheimer Pathogenesis in Amyloid Precursor Protein 23 Transgenic Mice
J. Neurosci., February 1, 2006; 26(5): 1343 - 1354.
[Abstract] [Full Text] [PDF]
S. E. Perez, O. Lazarov, J. B. Koprich, E.-Y. Chen, V. Rodriguez-Menendez, J. W. Lipton, S. S. Sisodia, and E. J. Mufson
Nigrostriatal Dysfunction in Familial Alzheimer's Disease-Linked APPswe/PS1{Delta}E9 Transgenic Mice
J. Neurosci., November 2, 2005; 25(44): 10220 - 10229.
[Abstract] [Full Text] [PDF]
B. P.F. Rutten, N. M. Van der Kolk, S. Schafer, M. A.M.J. van Zandvoort, T. A. Bayer, H. W.M. Steinbusch, and C. Schmitz
Age-Related Loss of Synaptophysin Immunoreactive Presynaptic Boutons within the Hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L Transgenic Mice
Am. J. Pathol., July 1, 2005; 167(1): 161 - 173.
[Abstract] [Full Text] [PDF]
G. B. Stokin, C. Lillo, T. L. Falzone, R. G. Brusch, E. Rockenstein, S. L. Mount, R. Raman, P. Davies, E. Masliah, D. S. Williams, et al.
Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease
Science, February 25, 2005; 307(5713): 1282 - 1288.
[Abstract] [Full Text] [PDF]
E. Masliah, M. Alford, A. Adame, E. Rockenstein, D. Galasko, D. Salmon, L. A. Hansen, and L. J. Thal
A{beta}1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD
Neurology, July 22, 2003; 61(2): 206 - 211.
[Abstract] [Full Text] [PDF]
B. Urbanc, L. Cruz, R. Le, J. Sanders, K. H. Ashe, K. Duff, H. E. Stanley, M. C. Irizarry, and B. T. Hyman
Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease
PNAS, October 29, 2002; 99(22): 13990 - 13995.
[Abstract] [Full Text] [PDF]
H. M. Fillit
The Role of Hormone Replacement Therapy in the Prevention of Alzheimer Disease
Arch Intern Med, September 23, 2002; 162(17): 1934 - 1942.
[Abstract] [Full Text] [PDF]
M. J. Savage, Y.-G. Lin, J. R. Ciallella, D. G. Flood, and R. W. Scott
Activation of c-Jun N-Terminal Kinase and p38 in an Alzheimer's Disease Model Is Associated with Amyloid Deposition
J. Neurosci., May 1, 2002; 22(9): 3376 - 3385.
[Abstract] [Full Text] [PDF]
S. Boncristiano, M. E. Calhoun, P. H. Kelly, M. Pfeifer, L. Bondolfi, M. Stalder, A. L. Phinney, D. Abramowski, C. Sturchler-Pierrat, A. Enz, et al.
Cholinergic Changes in the APP23 Transgenic Mouse Model of Cerebral Amyloidosis
J. Neurosci., April 15, 2002; 22(8): 3234 - 3243.
[Abstract] [Full Text] [PDF]
J. Q. Trojanowski
Neuropathological Verisimilitude in Animal Models of Alzheimer's Disease : Key to Elucidating Neurodegenerative Pathways and Identifying New Targets for Drug Discovery
Am. J. Pathol., February 1, 2002; 160(2): 409 - 411.
[Full Text] [PDF]
J.-T. Gau, M. L. Steinhilb, T.-C. Kao, C. J. D'Amato, J. R. Gaut, K. A. Frey, and R. S. Turner
Stable {beta}-Secretase Activity and Presynaptic Cholinergic Markers During Progressive Central Nervous System Amyloidogenesis in Tg2576 Mice
Am. J. Pathol., February 1, 2002; 160(2): 731 - 738.
[Abstract] [Full Text] [PDF]
R. S. Turner
Alzheimer's Disease in Man and Transgenic Mice : Females at Higher Risk
Am. J. Pathol., March 1, 2001; 158(3): 797 - 801.
[Full Text] [PDF]
A. Takeuchi, M. C. Irizarry, K. Duff, T. C. Saido, K. Hsiao Ashe, M. Hasegawa, D. M. A. Mann, B. T. Hyman, and T. Iwatsubo
Age-Related Amyloid {beta} Deposition in Transgenic Mice Overexpressing Both Alzheimer Mutant Presenilin 1 and Amyloid {beta} Precursor Protein Swedish Mutant Is Not Associated with Global Neuronal Loss
Am. J. Pathol., July 1, 2000; 157(1): 331 - 339.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|